Maura Dandri

Hamburg, HH 22529, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans.

Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans.

Journal: Scientific reports

Published: November 27, 2025

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Journal: JHEP reports : innovation in hepatology

Published: August 19, 2025

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Journal: JHEP reports : innovation in hepatology

Published: August 19, 2025

High hepatitis E virus prevalence in pig slurry samples from the north-western region of Germany.

High hepatitis E virus prevalence in pig slurry samples from the north-western region of Germany.

Journal: One health (Amsterdam, Netherlands)

Published: July 09, 2025

Targeting HBV with RNA interference: Paths to cure.

Targeting HBV with RNA interference: Paths to cure.

Journal: Science translational medicine

Published: July 02, 2025

Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCC.

Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCC.

Journal: Viruses

Published: February 24, 2025

Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study.

Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study.

Journal: Scientific reports

Published: February 18, 2025

Reply to: "Optimising the treatment of HDV infection: Efficacy of bulevirtide, HBV-HDV interactions and the importance of statistical methods".

Reply to: "Optimising the treatment of HDV infection: Efficacy of bulevirtide, HBV-HDV interactions and the importance of statistical methods".

Journal: Journal of hepatology

Published: October 18, 2024

SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential.

SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential.

Journal: Viruses

Published: September 09, 2024

Availability of point-of-care HBV tests in resource-limited settings.

Availability of point-of-care HBV tests in resource-limited settings.

Journal: The lancet. Gastroenterology & hepatology

Published: September 01, 2024

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 28, 2024

Method for Quantitative HDV RNA Detection: I, Manual Workflow (Serum and Liver Tissue) and II, Fully Automated High Throughput Workflow for Diagnostic Use.

Method for Quantitative HDV RNA Detection: I, Manual Workflow (Serum and Liver Tissue) and II, Fully Automated High Throughput Workflow for Diagnostic Use.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 23, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026